@murphai/murph 1.3.0 → 1.3.1

package/node_modules/@murphai/health-commons/generated/protocol-index.json

@@ -1,5 +1,5 @@
 {
-  "catalogHash": "sha256:341e9decb78df20c154363cae7dd79b56efedb3338a54084bfc65972dc5ab8a6",
+  "catalogHash": "sha256:4e191ad6aac0fcce6783a6a08a502f46a53e8ace0cc86bedcce988898f398017",
   "protocols": [
     {
       "aliases": [
@@ -575,52 +575,6 @@
         "sourceAttributed": false
       }
     },
-    {
-      "aliases": [
-        "whole-body photobiomodulation",
-        "full-body red light therapy",
-        "full-body red and near-infrared light therapy",
-        "whole-body LED light-bed exposure",
-        "red and near-infrared light bed",
-        "light bed photobiomodulation"
-      ],
-      "categories": [
-        "photobiomodulation",
-        "light",
-        "red-light",
-        "near-infrared",
-        "whole-body",
-        "sleep",
-        "recovery",
-        "wearable-measured"
-      ],
-      "entityType": "protocol_variant",
-      "key": "protocol_variant:whole-body-photobiomodulation/whole-body-red-and-near-infrared-light-exposure",
-      "relativePath": "protocols/whole-body-photobiomodulation/whole-body-red-and-near-infrared-light-exposure.md",
-      "revision": {
-        "pageRevisionId": "sha256:5e56b67d4c3d14802ced9ab4e0560a4fc0ea2c7177009a5814913aa08db01e08",
-        "recipeHash": "sha256:10263adfb74468fc8a737e74431954e39a22edd31fde554d011fcad596dc2740",
-        "runSpecRevisionId": "sha256:3c012a2e68daacc39492202b0a2bb6c72438a373ac67fc58f321477cba495240"
-      },
-      "routeId": "whole-body-red-and-near-infrared-light-exposure",
-      "routeIds": [
-        "whole-body-red-and-near-infrared-light-exposure",
-        "whole-body-photobiomodulation/whole-body-red-and-near-infrared-light-exposure",
-        "protocols/whole-body-photobiomodulation/whole-body-red-and-near-infrared-light-exposure"
-      ],
-      "searchText": "protocol_variant:whole-body-photobiomodulation/whole-body-red-and-near-infrared-light-exposure protocols/whole-body-photobiomodulation/whole-body-red-and-near-infrared-light-exposure Red Light Therapy Whole-body red/NIR light-bed exposure, where light reaches cells, changes how mitochondria handle energy and stress signals, and can release nitric oxide that relaxes blood vessels. whole-body photobiomodulation full-body red light therapy full-body red and near-infrared light therapy whole-body LED light-bed exposure red and near-infrared light bed light bed photobiomodulation photobiomodulation light red-light near-infrared whole-body sleep recovery wearable-measured doseSignature high-caution gated planning cadence · 3x/week · 12–20 min nonthermal whole-body red+NIR sessions with explicit parameter logging · 14-day baseline + 28-day intervention target documented non-UV, non-tanning, nonthermal whole-body red and near-infrared LED light-bed exposure with consistent session timing, geometry, coverage, and eye protection frequency sessionsPerWeek 3 durationMinutes min 12 max 20 sessionShape label One session segments kind ticks offsetMinutes interventionSessionsMinimum 10 interventionSessionsTarget steps Confirm device is documented non-UV, non-tanning, nonthermal red/NIR PBM; exclude sauna, tanning, IPL, laser, and heat protocols. Complete safety screen before start; route avoid/clinician-guidance items away from routine wellness setup. Use beginner/manufacturer setting and the lower of device instructions and Murph range; do not increase dose to chase effect. Record device, wavelengths, irradiance/fluence if known, intensity, pulsing, duration, geometry, coverage, and session orientation. Choose 1 stable session window; keep device, duration, timing, coverage, distance, and body position consistent. Use device-appropriate eye protection; avoid direct emitter gaze and keep sessions clearly nonthermal. Log symptoms, visual effects, skin changes, mood, sleep changes, medication changes, and confounders after each session. Stop for eye, skin, heat, mood, cardiopulmonary, neurologic, or severe symptoms; missed sessions beat pushing through. tips Report parameters, not marketing language. Wavelength alone is not the whole dose. Keep device, duration, timing, and coverage steady so a null result is still interpretable. Pair wearable data with one-tap subjective ratings for sleep, sleepiness, and recovery. A flat or negative result is useful information, not proof you did it wrong. keepInMind Direct human evidence for this exact general whole-body variant is limited. The closest controlled wellness record is a partial-body daytime 850 nm trial, not a literal whole-body light-bed trial. The strongest positive whole-body literature clusters in small supervised fibromyalgia or chronic-pain and cosmetic or photoaging contexts, with linked-program and endpoint-specific caveats that should not be silently borrowed into generic wellness claims. Time-of-day superiority is not settled for whole-body PBM. logFields device name and model manufacturer protocol or setting used wavelengths irradiance if known fluence if known intensity mode or pulsing if known session start time session duration front-only or front-and-back exposure body coverage or clothing distance or geometry room temperature or heat exposure skin warmth burning or pain during session eye protection type and fit accidental direct gaze into emitters afterimage duration visual symptoms skin redness rash blistering hyperpigmentation or irritation wounds lesions rash sunburn tattoos or skin changes in exposed areas medication changes including photosensitizing drugs PDT drugs retinoids steroids glucose medication or blood-pressure medication caffeine alcohol exercise sauna cold exposure travel illness stress or major diet changes new sleep recovery light heat cold supplement or training interventions bedtime and wake time naps wearable model or algorithm changes acute symptoms mood irritability agitation or lowered mood next-morning resting heart rate next-morning HRV or RMSSD sleep quality daytime sleepiness recovery or energy missed sessions and reason sessionFieldIds device_model irradiance_if_known fluence_if_known intensity_mode_or_pulsing_if_known session_start_time session_duration_minutes front_only_or_front_and_back exposure_geometry_distance_position body_coverage_or_clothing eye_protection_used accidental_direct_gaze nonthermal_comfort skin_warmth_burning_pain_or_irritation visual_symptoms_or_afterimage acute_symptoms mood_irritability_agitation_or_lowered_mood sleep_quality_next_morning daytime_sleepiness_next_day recovery_or_energy_next_day next_morning_resting_heart_rate next_morning_hrv_rmssd missed_session_reason stopConditions Stop the session immediately if you develop eye pain, blurred vision, new visual disturbance, unusual light sensitivity, new floaters, or an afterimage that does not resolve promptly. Stop the session immediately after accidental direct gaze into emitters if any eye or visual symptom persists. Stop the session if skin feels hot, burning, painful, or unusually warm. Stop the session if you develop blistering, persistent erythema, rash, hives, swelling, hyperpigmentation, herpes reactivation, or skin irritation that lasts beyond the session. Stop the session if any wound, lesion, tattooed area, rash, sunburn, or previously irritated skin area becomes painful, hot, red, or more irritated. End the experiment and seek appropriate medical guidance if you develop chest pain or tightness, palpitations, fainting, near-fainting, confusion, seizure symptoms, severe headache, severe dizziness, nausea, wheezing, dyspnea at rest, or unusual shortness of breath. End the experiment if repeated sessions are followed by clearly worse sleep, insomnia, agitation, irritability, hypomania or mania-like symptoms, lowered mood, or mood instability without a better explanation. Do not continue to meet an adherence target after any stop condition; missed sessions are preferable to pushing through symptoms. cautionLevel high avoidOrGetClinicianGuidance pregnancy_lactation_or_breastfeeding under_18_years_old active_or_recent_cancer_treatment skin_cancer_history concerning_or_changing_skin_lesions recent_photodynamic_therapy_drug photosensitizing_medication photosensitivity_or_photophobia light_triggered_symptoms retinoid_or_steroid_impairing_healing seizure_disorder_or_photosensitive_epilepsy eye_disease_or_retinal_disease recent_eye_surgery unresolved_visual_symptoms implanted_electrical_or_medical_device pacemaker arrhythmia_or_unstable_cardiovascular severe_hypertension unstable_cardiometabolic_disease diabetes_with_severe_complications insulin_dependence_unstable_glucose planned_medication_holds unstable_neurologic_disease severe_cognitive_or_sensory_impairment significant_pulmonary_disease dyspnea_at_rest_or_hypoxemia thyroid_or_parathyroid_with_neck_exposed severe_psychiatric_instability bipolar_or_mania_hypomania_risk diagnosed_sleep_disorder night_shift_or_recent_timezone_travel open_wounds_burns_or_sunburn active_rash_or_skin_infection herpes_outbreak_in_exposed_areas concerning_lesions_in_exposed_areas inability_to_detect_heat_or_pain unable_to_follow_device_instructions device_fit_or_positioning_constraints stopIf eye pain blurred vision visual disturbance unusual light sensitivity new floaters or persistent afterimage accidental direct gaze into emitters followed by lingering visual symptoms skin feels hot burning painful or unusually warm blistering persistent erythema rash hives swelling hyperpigmentation herpes reactivation or persistent skin irritation wound lesion tattoo rash sunburn or skin-cancer site irritation severe headache dizziness nausea vomiting confusion fainting or near-fainting seizure symptoms or seizure aura chest pain chest tightness palpitations wheezing dyspnea at rest or unusual shortness of breath repeated worsening sleep insomnia agitation irritability hypomania or mania-like symptoms lowered mood or unstable mood notes Bounded field test with gated onboarding — not disease treatment or auto-experiment creation. Use only documented non-UV, nonthermal red/NIR PBM devices — no sauna, tanning, IPL, laser, or heat. Wear device-appropriate eye protection every session and avoid direct emitter gaze. Do not stop, hold, or change prescribed medication for this protocol. Missed sessions are fine — never push through symptoms to meet adherence. Safety language stays stronger than efficacy language — direct evidence is still sparse. planId whole-body-pbm-rhr-sleep-42d durationDays 42 baselineDays 14 interventionDays 28 primaryBiomarkerKey biomarker:resting-heart-rate secondaryBiomarkerKeys biomarker:hrv-rmssd biomarker:sleep-efficiency biomarker:deep-sleep-minutes minimumAdherenceSessions targetAdherenceSessions The main practical question is whether a stable whole-body red/NIR routine lowers overnight resting pulse or lifts RMSSD without shortening sleep. Use wearable metrics as repeated signals, not as single-night verdicts. Keep session timing and exposure setup consistent enough that you can interpret either a positive or null result. Log subjective sleep quality and daytime sleepiness as interpretation context beside RHR, RMSSD, and sleep-continuity trends. biomarkerKey description Red/NIR exposure supports nitric-oxide signaling and inflammatory balance, lowering overnight recovery demand and resting pulse. expected Could trend lower expectedDirection down_or_stable displayValue Up to 5 bpm lower estimatedChange absolute low -5 0 unit bpm window 4 weeks confidence basis Adjacent partial-body 850 nm RCT data showed -4.60 +/- 1.90 bpm in winter at 6.5 J/cm^2; whole-body athlete implementation data also showed lower nocturnal heart rate, while direct general whole-body registries have no posted outcomes. protocolProminence focus Lower recovery load gives the vagal system more room to rebound during sleep, raising RMSSD. Could rise or stay stable up_or_stable relative_percent % next morning to 4 weeks An acute whole-body pre-exercise crossover trial found higher next-morning rMSSD versus placebo, and athlete implementation data showed a numerical HRV increase; neither source proves a durable general-wellness shift. A calmer, less uncomfortable night may reduce quiet-wake minutes, but controlled sleep effects remain unclear. Small or no clear change mixed_or_contextual -1 2 The closest controlled 850 nm wellness trial did not show significant sleep or circadian effects; direct whole-body sleep registries selected Oura and sleep-quality endpoints but do not yet provide outcome data. context Red light has no proven effect on deep sleep; a shift of a few minutes either way is usually normal night-to-night variation. Small or no change -10 minutes No extracted study directly anchors N3 or wearable deep-sleep minutes for this protocol; the range reflects a noisy same-device context signal around otherwise null or mixed sleep findings. schemaVersion murph.commons.experiment-onboarding.v2 startIntent displayPrompt Hey Murph, I want to cautiously plan a Red Light Therapy experiment. intentSummary Explore Red Light Therapy safetyScreen dispositionIfAnyPositive clinician_guidance_before_unsupervised_start mustAsk id prompt ifPositive additionalConditions setupSlots Device model question What exact whole-body red/NIR PBM device model would you use? object field Red/NIR wavelengths What red and near-infrared wavelengths does the device report for the mode you plan to use? irradiance_fluence Irradiance or fluence What irradiance and/or fluence does the device report for your distance, mode, and session length? If unavailable, say unknown and keep the run parameter-logged rather than dose-claimed. Session duration How many minutes will each session last? This starter caps sessions at 20 minutes and should start at the lower of the device instructions and the candidate range. constraints default recommendedOptions session_timing Session timing Which stable session window is realistic for the 28-day intervention? options exposure_geometry_body_coverage Exposure geometry and body coverage What exposure geometry will you use: distance, front-only or front-and-back, position, clothing/body coverage, and any areas excluded? eye_protection Eye protection What device-appropriate eye protection will you use for every session, and how will you avoid direct emitter gaze? Nonthermal comfort Can you keep sessions clearly nonthermal and stop immediately if skin feels hot, burning, painful, or unusually warm? logging_path Logging path Where should Murph record session parameters, symptoms, confounders, and next-morning sleep/recovery ratings? reminder_policy Reminder preference Do you want reminders for the three weekly sessions and any missing logs? askWhen planDefaults testPlanId firstSessionGuidance Start at the lower of the device beginner instructions and the 12-20 minute candidate range, keep the session clearly nonthermal, use eye protection, avoid direct emitter gaze, and log all device parameters and symptoms. trackingHints confounderFields bedtime_or_wake_time_change caffeine_alcohol_or_late_meal_change exercise_training_load_change sauna_heat_cold_or_light_intervention new_sleep_recovery_supplement_or_skin_intervention medication_change_or_photosensitizing_exposure illness_pain_travel_or_timezone_shift major_stress wearable_model_or_algorithm_change wounds_rash_sunburn_tattoo_or_skin_irritation Missing sessions should be logged honestly; do not make up adherence by continuing through symptoms. Irradiance or fluence may be unknown for some consumer devices, but the unknown must be recorded and should limit dose claims. supportHints missedLogFollowupCopy Did you complete or intentionally skip the whole-body red/NIR PBM session today? Either answer is useful — I just want the experiment record to be accurate. ## Light is dose, not color\n\nRed/NIR PBM depends on wavelength, irradiance, fluence, duration, distance, and coverage. Marketing color names do not define the biological exposure. ## Cells shift signaling\n\nPhotons affect mitochondrial, nitric-oxide, inflammatory, and oxidative-stress pathways. The effect is nonthermal; heat turns it into a different protocol. ## Recovery signal is systemic but weak\n\nLarge-area exposure can change autonomic or vascular tone. Resting HR and RMSSD track whether recovery load drops without overclaiming sleep or performance. claimId page-scope-is-one-variant-not-all-red-light type evidence_scope text This page is for one cautious Murph variant of whole-body red and near-infrared photobiomodulation, not for every red-light therapy use case, all PBM, or all light-based sleep interventions. strength sourceKeys source_artifact:pmid-40253006 source_artifact:pmid-36927734 source_artifact:pmid-37593770 source_artifact:pmid-37002704 source_artifact:pmid-19602651 source_artifact:iarc-sunbeds-uv-radiation-2009-07-29 direct-general-evidence-is-thin mixed_evidence Direct evidence for a general whole-body red/NIR wellness or sleep protocol is limited; the nearest direct records include registries without extracted outcomes and one acute crossover study in women-only cohorts. moderate source_artifact:clinicaltrials-gov-nct05116605-2026-04-23 source_artifact:clinicaltrials-gov-nct05963555-2026-04-23 source_artifact:pmid-41228430 closest-controlled-wellness-trial-is-adjacent The closest controlled wellness trial that is often tempting to cite is not literal whole-body bed evidence; it used daytime 850 nm exposure limited to face, neck, and hands and did not show significant sleep or circadian benefit. source_artifact:pmid-36671752 implementation-needs-explicit-dose-logging design_guardrail Whole-body PBM should be logged as an explicit delivered-light setup, not just as 'did red light,' because wavelength, irradiance, fluence, duration, repetition, and geometry are all plausibly load-bearing. source_artifact:pmid-30550048 source_artifact:fda-pbm-devices-guidance-2023-01-12 source_artifact:pmid-30044464 sibling-variant-literatures-should-stay-separate Athlete recovery, fibromyalgia, chronic-pain, cosmetic/photoaging, transcranial, intranasal, bright-light, infrared-sauna, and UV-tanning literatures should not be silently reused as direct support for this page. source_artifact:pmid-39883205 source_artifact:pmid-36369323 source_artifact:pmid-38356644 source_artifact:pmid-24286286 short-term-tolerability-bounded-not-settled safety Short-term supervised or study-context tolerability looks somewhat reassuring, but the safety record is still too sparse and too context-specific to justify blanket unsupervised reassurance. source_artifact:pmid-31483941 source_artifact:pmid-39672511 source_artifact:pmid-38180093 source_artifact:pmid-39335685 source_artifact:pmid-28891192 source_artifact:bmla-drugs-and-lasers-ipls-2018-11-30 source_artifact:pmid-34021422 source_artifact:pmid-36110957 source_artifact:pmid-33107198 screening-boundaries-come-from-supervised-protocols Pregnancy or lactation, seizure risk, photophobia or photosensitivity, photosensitizing drugs, implanted devices or pacemakers, unstable cardiovascular, metabolic, neurologic, pulmonary, or psychiatric disease, diabetes medication constraints, active or recent cancer treatment, skin-cancer history, open wounds, concerning lesions, thyroid problems, and inability to report thermal sensation should be clinician-guidance boundaries because they recur as exclusions or safety constraints in supervised or registered whole-body PBM protocols. source_artifact:clinicaltrials-gov-nct06678698-2026-04-23 source_artifact:clinicaltrials-gov-nct07047248-2026-04-23 source_artifact:clinicaltrials-gov-nct07271927-2026-04-23 source_artifact:ensaiosclinicos-rbr-8v7rsdp-2026-04-23 source_artifact:ensaiosclinicos-rbr-9vcph8x-2026-04-23 source_artifact:clinicaltrials-gov-nct06866522-2026-04-23 photosensitizing-and-healing-risk-medications-need-separate-screening Medication screening should be wavelength-aware and should not be reduced to a generic 'red light is safe' statement: photosensitizing drugs can cause clinically meaningful skin or ocular risk, recent systemic or topical photodynamic therapy drugs warrant stronger waiting-period precautions, and retinoids or steroids may raise healing-risk questions. source_artifact:pmid-34451820 source_artifact:pmid-24590242 eye-protection-and-no-direct-gaze-are-required-guardrails Eye risk appears controllable, not ignorable: adjacent ocular and facial-light sources document transient ocular complaints, afterimages, reversible retinal findings, photochemical risk from direct viewing, and injury risk when protection or positioning fails, so no-direct-gaze and eye-protection instructions belong on the main page. high-local-dose-red-light-can-cause-skin-reactions Short-term whole-body tolerability should not be treated as dose-indifference: adjacent human red-light skin-safety trials reported dose-limiting blistering and prolonged erythema at higher local fluences, plus milder transient erythema and hyperpigmentation. cancer-context-is-clinician-guided-not-blanket-reassurance Cancer-related PBM evidence is more reassuring in supervised supportive-care follow-up than in some preclinical or mixed reviews, but it does not justify routine unsupervised whole-body wellness use during active or recent cancer treatment; oncology contexts should stay clinician-guided. source_artifact:pmid-31109692 source_artifact:pmid-29466089 gated-planning-only-onboarding This protocol can support only a high-caution, planning-first Murph onboarding path: the assistant may gather safety, device, dose, timing, eye-protection, exposure-geometry, logging, and reminder details, but should not create an active experiment or automation until the user explicitly confirms the limited-evidence posture and all required setup gates. Red Light Therapy is plausible enough for cautious field testing when implemented as whole-body red and near-infrared photobiomodulation, but the direct evidence for this exact Murph variant is much thinner than the broader PBM internet narrative suggests.\n\n## What this page is trying to answer\n\nThis page asks a narrow question: if someone uses a **nonthermal whole-body red/NIR light-bed setup** in a consistent, explicitly logged way for four weeks, is there a detectable personal signal in sleep, next-day sleepiness, recovery, or resting heart rate?\n\n## Why this version is cautious\n\nThe direct literature is not strong enough to promise a result. The strongest general-wellness controlled record in the landing set is a **partial-body** daytime 850 nm trial with winter-only mood, drowsiness, inflammatory, and resting-heart-rate signals but **no significant sleep or circadian benefit**. The direct whole-body sleep records are mainly registries that help with cadence, endpoints, and exclusions rather than with efficacy. Acute direct whole-body evidence also exists in a narrow women-only metabolic study, but that is not a general sleep study.\n\n## Who should not use this as an ordinary self-experiment\n\nDo not use this ordinary wellness protocol without clinician guidance if you are pregnant or breastfeeding; are under 18; have seizure risk, photophobia, photosensitivity, eye disease, recent eye surgery, active or recent cancer treatment, skin-cancer history, suspicious or changing skin lesions, thyroid disease, an implanted medical device, unstable cardiovascular, metabolic, neurologic, pulmonary, or psychiatric disease, diabetes medication constraints, open wounds, active rash, sunburn, skin infection, herpes outbreak, or recent photodynamic therapy drug exposure. Also do not use this protocol if you cannot reliably detect or report heat, pain, skin symptoms, or visual symptoms. These boundaries come from safety reviews, medication guidance, and supervised or registered protocol exclusions rather than from proven risk rates.\n\n\n## What stays separate\n\nThis page is not the place to import efficacy claims from athlete recovery beds, fibromyalgia or chronic-pain PBM, cosmetic or photoaging beds, transcranial or intranasal PBM, red-light glasses, bright-light therapy, infrared sauna, or UV tanning. The athlete/recovery bucket is mixed and includes null performance and fatigue-biomarker evidence; fibromyalgia and cosmetic signals are condition- or endpoint-specific. Those literatures help define boundaries, not generic efficacy.\n\n## Stop rules\n\nStop the session immediately for eye pain, blurred vision, visual disturbance, unusual light sensitivity, new floaters, a persistent afterimage, accidental direct gaze followed by lingering symptoms, burning or hot skin, blistering, persistent redness, rash, swelling, wound or lesion irritation, severe headache, dizziness, nausea, confusion, fainting, seizure symptoms, chest symptoms, palpitations, wheezing, unusual shortness of breath, or marked mood or sleep worsening. Do not finish sessions just to hit an adherence target. Eye, skin, medication, and mood-related adverse-event signals are mostly adjacent rather than direct whole-body evidence, which is exactly why the stop rules should be stricter than the efficacy language.\n\n## How to read your result\n\nA positive result would mean your own baseline shifted in a repeatable direction while device, timing, coverage, and other confounders stayed fairly stable. A null or mixed result is still informative here, and worsening sleep duration or sleep-stage estimates should be treated as a real negative signal rather than ignored, because adjacent repeated-use wearable data include both lower sleeping heart rate and shorter sleep durations.",
-      "slug": "protocols/whole-body-photobiomodulation/whole-body-red-and-near-infrared-light-exposure",
-      "status": "field-testing",
-      "summary": "Whole-body red/NIR light-bed exposure, where light reaches cells, changes how mitochondria handle energy and stress signals, and can release nitric oxide that relaxes blood vessels.",
-      "title": "Red Light Therapy",
-      "traits": {
-        "cautionLevel": "high",
-        "externalProtocol": false,
-        "highCaution": true,
-        "murphCanonical": false,
-        "sourceAttributed": false
-      }
-    },
     {
       "aliases": [
         "Tabata 20/10",
@@ -715,6 +669,52 @@
         "murphCanonical": true,
         "sourceAttributed": false
       }
+    },
+    {
+      "aliases": [
+        "whole-body photobiomodulation",
+        "full-body red light therapy",
+        "full-body red and near-infrared light therapy",
+        "whole-body LED light-bed exposure",
+        "red and near-infrared light bed",
+        "light bed photobiomodulation"
+      ],
+      "categories": [
+        "photobiomodulation",
+        "light",
+        "red-light",
+        "near-infrared",
+        "whole-body",
+        "sleep",
+        "recovery",
+        "wearable-measured"
+      ],
+      "entityType": "protocol_variant",
+      "key": "protocol_variant:whole-body-photobiomodulation/whole-body-red-and-near-infrared-light-exposure",
+      "relativePath": "protocols/whole-body-photobiomodulation/whole-body-red-and-near-infrared-light-exposure.md",
+      "revision": {
+        "pageRevisionId": "sha256:58af9b0b64401efda9307afd32856669ad63c125bd10729e1355a1937c032ad7",
+        "recipeHash": "sha256:10263adfb74468fc8a737e74431954e39a22edd31fde554d011fcad596dc2740",
+        "runSpecRevisionId": "sha256:3c012a2e68daacc39492202b0a2bb6c72438a373ac67fc58f321477cba495240"
+      },
+      "routeId": "whole-body-red-and-near-infrared-light-exposure",
+      "routeIds": [
+        "whole-body-red-and-near-infrared-light-exposure",
+        "whole-body-photobiomodulation/whole-body-red-and-near-infrared-light-exposure",
+        "protocols/whole-body-photobiomodulation/whole-body-red-and-near-infrared-light-exposure"
+      ],
+      "searchText": "protocol_variant:whole-body-photobiomodulation/whole-body-red-and-near-infrared-light-exposure protocols/whole-body-photobiomodulation/whole-body-red-and-near-infrared-light-exposure Whole-Body Red and Near-Infrared Light Exposure Whole-body red/NIR light-bed exposure, where light reaches cells, changes how mitochondria handle energy and stress signals, and can release nitric oxide that relaxes blood vessels. whole-body photobiomodulation full-body red light therapy full-body red and near-infrared light therapy whole-body LED light-bed exposure red and near-infrared light bed light bed photobiomodulation photobiomodulation light red-light near-infrared whole-body sleep recovery wearable-measured doseSignature high-caution gated planning cadence · 3x/week · 12–20 min nonthermal whole-body red+NIR sessions with explicit parameter logging · 14-day baseline + 28-day intervention target documented non-UV, non-tanning, nonthermal whole-body red and near-infrared LED light-bed exposure with consistent session timing, geometry, coverage, and eye protection frequency sessionsPerWeek 3 durationMinutes min 12 max 20 sessionShape label One session segments kind ticks offsetMinutes interventionSessionsMinimum 10 interventionSessionsTarget steps Confirm device is documented non-UV, non-tanning, nonthermal red/NIR PBM; exclude sauna, tanning, IPL, laser, and heat protocols. Complete safety screen before start; route avoid/clinician-guidance items away from routine wellness setup. Use beginner/manufacturer setting and the lower of device instructions and Murph range; do not increase dose to chase effect. Record device, wavelengths, irradiance/fluence if known, intensity, pulsing, duration, geometry, coverage, and session orientation. Choose 1 stable session window; keep device, duration, timing, coverage, distance, and body position consistent. Use device-appropriate eye protection; avoid direct emitter gaze and keep sessions clearly nonthermal. Log symptoms, visual effects, skin changes, mood, sleep changes, medication changes, and confounders after each session. Stop for eye, skin, heat, mood, cardiopulmonary, neurologic, or severe symptoms; missed sessions beat pushing through. tips Report parameters, not marketing language. Wavelength alone is not the whole dose. Keep device, duration, timing, and coverage steady so a null result is still interpretable. Pair wearable data with one-tap subjective ratings for sleep, sleepiness, and recovery. A flat or negative result is useful information, not proof you did it wrong. keepInMind Direct human evidence for this exact general whole-body variant is limited. The closest controlled wellness record is a partial-body daytime 850 nm trial, not a literal whole-body light-bed trial. The strongest positive whole-body literature clusters in small supervised fibromyalgia or chronic-pain and cosmetic or photoaging contexts, with linked-program and endpoint-specific caveats that should not be silently borrowed into generic wellness claims. Time-of-day superiority is not settled for whole-body PBM. logFields device name and model manufacturer protocol or setting used wavelengths irradiance if known fluence if known intensity mode or pulsing if known session start time session duration front-only or front-and-back exposure body coverage or clothing distance or geometry room temperature or heat exposure skin warmth burning or pain during session eye protection type and fit accidental direct gaze into emitters afterimage duration visual symptoms skin redness rash blistering hyperpigmentation or irritation wounds lesions rash sunburn tattoos or skin changes in exposed areas medication changes including photosensitizing drugs PDT drugs retinoids steroids glucose medication or blood-pressure medication caffeine alcohol exercise sauna cold exposure travel illness stress or major diet changes new sleep recovery light heat cold supplement or training interventions bedtime and wake time naps wearable model or algorithm changes acute symptoms mood irritability agitation or lowered mood next-morning resting heart rate next-morning HRV or RMSSD sleep quality daytime sleepiness recovery or energy missed sessions and reason sessionFieldIds device_model irradiance_if_known fluence_if_known intensity_mode_or_pulsing_if_known session_start_time session_duration_minutes front_only_or_front_and_back exposure_geometry_distance_position body_coverage_or_clothing eye_protection_used accidental_direct_gaze nonthermal_comfort skin_warmth_burning_pain_or_irritation visual_symptoms_or_afterimage acute_symptoms mood_irritability_agitation_or_lowered_mood sleep_quality_next_morning daytime_sleepiness_next_day recovery_or_energy_next_day next_morning_resting_heart_rate next_morning_hrv_rmssd missed_session_reason stopConditions Stop the session immediately if you develop eye pain, blurred vision, new visual disturbance, unusual light sensitivity, new floaters, or an afterimage that does not resolve promptly. Stop the session immediately after accidental direct gaze into emitters if any eye or visual symptom persists. Stop the session if skin feels hot, burning, painful, or unusually warm. Stop the session if you develop blistering, persistent erythema, rash, hives, swelling, hyperpigmentation, herpes reactivation, or skin irritation that lasts beyond the session. Stop the session if any wound, lesion, tattooed area, rash, sunburn, or previously irritated skin area becomes painful, hot, red, or more irritated. End the experiment and seek appropriate medical guidance if you develop chest pain or tightness, palpitations, fainting, near-fainting, confusion, seizure symptoms, severe headache, severe dizziness, nausea, wheezing, dyspnea at rest, or unusual shortness of breath. End the experiment if repeated sessions are followed by clearly worse sleep, insomnia, agitation, irritability, hypomania or mania-like symptoms, lowered mood, or mood instability without a better explanation. Do not continue to meet an adherence target after any stop condition; missed sessions are preferable to pushing through symptoms. cautionLevel high avoidOrGetClinicianGuidance pregnancy_lactation_or_breastfeeding under_18_years_old active_or_recent_cancer_treatment skin_cancer_history concerning_or_changing_skin_lesions recent_photodynamic_therapy_drug photosensitizing_medication photosensitivity_or_photophobia light_triggered_symptoms retinoid_or_steroid_impairing_healing seizure_disorder_or_photosensitive_epilepsy eye_disease_or_retinal_disease recent_eye_surgery unresolved_visual_symptoms implanted_electrical_or_medical_device pacemaker arrhythmia_or_unstable_cardiovascular severe_hypertension unstable_cardiometabolic_disease diabetes_with_severe_complications insulin_dependence_unstable_glucose planned_medication_holds unstable_neurologic_disease severe_cognitive_or_sensory_impairment significant_pulmonary_disease dyspnea_at_rest_or_hypoxemia thyroid_or_parathyroid_with_neck_exposed severe_psychiatric_instability bipolar_or_mania_hypomania_risk diagnosed_sleep_disorder night_shift_or_recent_timezone_travel open_wounds_burns_or_sunburn active_rash_or_skin_infection herpes_outbreak_in_exposed_areas concerning_lesions_in_exposed_areas inability_to_detect_heat_or_pain unable_to_follow_device_instructions device_fit_or_positioning_constraints stopIf eye pain blurred vision visual disturbance unusual light sensitivity new floaters or persistent afterimage accidental direct gaze into emitters followed by lingering visual symptoms skin feels hot burning painful or unusually warm blistering persistent erythema rash hives swelling hyperpigmentation herpes reactivation or persistent skin irritation wound lesion tattoo rash sunburn or skin-cancer site irritation severe headache dizziness nausea vomiting confusion fainting or near-fainting seizure symptoms or seizure aura chest pain chest tightness palpitations wheezing dyspnea at rest or unusual shortness of breath repeated worsening sleep insomnia agitation irritability hypomania or mania-like symptoms lowered mood or unstable mood notes Bounded field test with gated onboarding — not disease treatment or auto-experiment creation. Use only documented non-UV, nonthermal red/NIR PBM devices — no sauna, tanning, IPL, laser, or heat. Wear device-appropriate eye protection every session and avoid direct emitter gaze. Do not stop, hold, or change prescribed medication for this protocol. Missed sessions are fine — never push through symptoms to meet adherence. Safety language stays stronger than efficacy language — direct evidence is still sparse. planId whole-body-pbm-rhr-sleep-42d durationDays 42 baselineDays 14 interventionDays 28 primaryBiomarkerKey biomarker:resting-heart-rate secondaryBiomarkerKeys biomarker:hrv-rmssd biomarker:sleep-efficiency biomarker:deep-sleep-minutes minimumAdherenceSessions targetAdherenceSessions The main practical question is whether a stable whole-body red/NIR routine lowers overnight resting pulse or lifts RMSSD without shortening sleep. Use wearable metrics as repeated signals, not as single-night verdicts. Keep session timing and exposure setup consistent enough that you can interpret either a positive or null result. Log subjective sleep quality and daytime sleepiness as interpretation context beside RHR, RMSSD, and sleep-continuity trends. biomarkerKey description Red/NIR exposure supports nitric-oxide signaling and inflammatory balance, lowering overnight recovery demand and resting pulse. expected Could trend lower expectedDirection down_or_stable displayValue Up to 5 bpm lower estimatedChange absolute low -5 0 unit bpm window 4 weeks confidence basis Adjacent partial-body 850 nm RCT data showed -4.60 +/- 1.90 bpm in winter at 6.5 J/cm^2; whole-body athlete implementation data also showed lower nocturnal heart rate, while direct general whole-body registries have no posted outcomes. protocolProminence focus Lower recovery load gives the vagal system more room to rebound during sleep, raising RMSSD. Could rise or stay stable up_or_stable relative_percent % next morning to 4 weeks An acute whole-body pre-exercise crossover trial found higher next-morning rMSSD versus placebo, and athlete implementation data showed a numerical HRV increase; neither source proves a durable general-wellness shift. A calmer, less uncomfortable night may reduce quiet-wake minutes, but controlled sleep effects remain unclear. Small or no clear change mixed_or_contextual -1 2 The closest controlled 850 nm wellness trial did not show significant sleep or circadian effects; direct whole-body sleep registries selected Oura and sleep-quality endpoints but do not yet provide outcome data. context Red light has no proven effect on deep sleep; a shift of a few minutes either way is usually normal night-to-night variation. Small or no change -10 minutes No extracted study directly anchors N3 or wearable deep-sleep minutes for this protocol; the range reflects a noisy same-device context signal around otherwise null or mixed sleep findings. schemaVersion murph.commons.experiment-onboarding.v2 startIntent displayPrompt Hey Murph, I want to cautiously plan a Red Light Therapy experiment. intentSummary Explore Red Light Therapy safetyScreen dispositionIfAnyPositive clinician_guidance_before_unsupervised_start mustAsk id prompt ifPositive additionalConditions setupSlots Device model question What exact whole-body red/NIR PBM device model would you use? object field Red/NIR wavelengths What red and near-infrared wavelengths does the device report for the mode you plan to use? irradiance_fluence Irradiance or fluence What irradiance and/or fluence does the device report for your distance, mode, and session length? If unavailable, say unknown and keep the run parameter-logged rather than dose-claimed. Session duration How many minutes will each session last? This starter caps sessions at 20 minutes and should start at the lower of the device instructions and the candidate range. constraints default recommendedOptions session_timing Session timing Which stable session window is realistic for the 28-day intervention? options exposure_geometry_body_coverage Exposure geometry and body coverage What exposure geometry will you use: distance, front-only or front-and-back, position, clothing/body coverage, and any areas excluded? eye_protection Eye protection What device-appropriate eye protection will you use for every session, and how will you avoid direct emitter gaze? Nonthermal comfort Can you keep sessions clearly nonthermal and stop immediately if skin feels hot, burning, painful, or unusually warm? logging_path Logging path Where should Murph record session parameters, symptoms, confounders, and next-morning sleep/recovery ratings? reminder_policy Reminder preference Do you want reminders for the three weekly sessions and any missing logs? askWhen planDefaults testPlanId firstSessionGuidance Start at the lower of the device beginner instructions and the 12-20 minute candidate range, keep the session clearly nonthermal, use eye protection, avoid direct emitter gaze, and log all device parameters and symptoms. trackingHints confounderFields bedtime_or_wake_time_change caffeine_alcohol_or_late_meal_change exercise_training_load_change sauna_heat_cold_or_light_intervention new_sleep_recovery_supplement_or_skin_intervention medication_change_or_photosensitizing_exposure illness_pain_travel_or_timezone_shift major_stress wearable_model_or_algorithm_change wounds_rash_sunburn_tattoo_or_skin_irritation Missing sessions should be logged honestly; do not make up adherence by continuing through symptoms. Irradiance or fluence may be unknown for some consumer devices, but the unknown must be recorded and should limit dose claims. supportHints missedLogFollowupCopy Did you complete or intentionally skip the whole-body red/NIR PBM session today? Either answer is useful — I just want the experiment record to be accurate. ## Light is dose, not color\n\nRed/NIR PBM depends on wavelength, irradiance, fluence, duration, distance, and coverage. Marketing color names do not define the biological exposure. ## Cells shift signaling\n\nPhotons affect mitochondrial, nitric-oxide, inflammatory, and oxidative-stress pathways. The effect is nonthermal; heat turns it into a different protocol. ## Recovery signal is systemic but weak\n\nLarge-area exposure can change autonomic or vascular tone. Resting HR and RMSSD track whether recovery load drops without overclaiming sleep or performance. claimId page-scope-is-one-variant-not-all-red-light type evidence_scope text This page is for one cautious Murph variant of whole-body red and near-infrared photobiomodulation, not for every red-light therapy use case, all PBM, or all light-based sleep interventions. strength sourceKeys source_artifact:pmid-40253006 source_artifact:pmid-36927734 source_artifact:pmid-37593770 source_artifact:pmid-37002704 source_artifact:pmid-19602651 source_artifact:iarc-sunbeds-uv-radiation-2009-07-29 direct-general-evidence-is-thin mixed_evidence Direct evidence for a general whole-body red/NIR wellness or sleep protocol is limited; the nearest direct records include registries without extracted outcomes and one acute crossover study in women-only cohorts. moderate source_artifact:clinicaltrials-gov-nct05116605-2026-04-23 source_artifact:clinicaltrials-gov-nct05963555-2026-04-23 source_artifact:pmid-41228430 closest-controlled-wellness-trial-is-adjacent The closest controlled wellness trial that is often tempting to cite is not literal whole-body bed evidence; it used daytime 850 nm exposure limited to face, neck, and hands and did not show significant sleep or circadian benefit. source_artifact:pmid-36671752 implementation-needs-explicit-dose-logging design_guardrail Whole-body PBM should be logged as an explicit delivered-light setup, not just as 'did red light,' because wavelength, irradiance, fluence, duration, repetition, and geometry are all plausibly load-bearing. source_artifact:pmid-30550048 source_artifact:fda-pbm-devices-guidance-2023-01-12 source_artifact:pmid-30044464 sibling-variant-literatures-should-stay-separate Athlete recovery, fibromyalgia, chronic-pain, cosmetic/photoaging, transcranial, intranasal, bright-light, infrared-sauna, and UV-tanning literatures should not be silently reused as direct support for this page. source_artifact:pmid-39883205 source_artifact:pmid-36369323 source_artifact:pmid-38356644 source_artifact:pmid-24286286 short-term-tolerability-bounded-not-settled safety Short-term supervised or study-context tolerability looks somewhat reassuring, but the safety record is still too sparse and too context-specific to justify blanket unsupervised reassurance. source_artifact:pmid-31483941 source_artifact:pmid-39672511 source_artifact:pmid-38180093 source_artifact:pmid-39335685 source_artifact:pmid-28891192 source_artifact:bmla-drugs-and-lasers-ipls-2018-11-30 source_artifact:pmid-34021422 source_artifact:pmid-36110957 source_artifact:pmid-33107198 screening-boundaries-come-from-supervised-protocols Pregnancy or lactation, seizure risk, photophobia or photosensitivity, photosensitizing drugs, implanted devices or pacemakers, unstable cardiovascular, metabolic, neurologic, pulmonary, or psychiatric disease, diabetes medication constraints, active or recent cancer treatment, skin-cancer history, open wounds, concerning lesions, thyroid problems, and inability to report thermal sensation should be clinician-guidance boundaries because they recur as exclusions or safety constraints in supervised or registered whole-body PBM protocols. source_artifact:clinicaltrials-gov-nct06678698-2026-04-23 source_artifact:clinicaltrials-gov-nct07047248-2026-04-23 source_artifact:clinicaltrials-gov-nct07271927-2026-04-23 source_artifact:ensaiosclinicos-rbr-8v7rsdp-2026-04-23 source_artifact:ensaiosclinicos-rbr-9vcph8x-2026-04-23 source_artifact:clinicaltrials-gov-nct06866522-2026-04-23 photosensitizing-and-healing-risk-medications-need-separate-screening Medication screening should be wavelength-aware and should not be reduced to a generic 'red light is safe' statement: photosensitizing drugs can cause clinically meaningful skin or ocular risk, recent systemic or topical photodynamic therapy drugs warrant stronger waiting-period precautions, and retinoids or steroids may raise healing-risk questions. source_artifact:pmid-34451820 source_artifact:pmid-24590242 eye-protection-and-no-direct-gaze-are-required-guardrails Eye risk appears controllable, not ignorable: adjacent ocular and facial-light sources document transient ocular complaints, afterimages, reversible retinal findings, photochemical risk from direct viewing, and injury risk when protection or positioning fails, so no-direct-gaze and eye-protection instructions belong on the main page. high-local-dose-red-light-can-cause-skin-reactions Short-term whole-body tolerability should not be treated as dose-indifference: adjacent human red-light skin-safety trials reported dose-limiting blistering and prolonged erythema at higher local fluences, plus milder transient erythema and hyperpigmentation. cancer-context-is-clinician-guided-not-blanket-reassurance Cancer-related PBM evidence is more reassuring in supervised supportive-care follow-up than in some preclinical or mixed reviews, but it does not justify routine unsupervised whole-body wellness use during active or recent cancer treatment; oncology contexts should stay clinician-guided. source_artifact:pmid-31109692 source_artifact:pmid-29466089 gated-planning-only-onboarding This protocol can support only a high-caution, planning-first Murph onboarding path: the assistant may gather safety, device, dose, timing, eye-protection, exposure-geometry, logging, and reminder details, but should not create an active experiment or automation until the user explicitly confirms the limited-evidence posture and all required setup gates. Red Light Therapy is plausible enough for cautious field testing when implemented as whole-body red and near-infrared photobiomodulation, but the direct evidence for this exact Murph variant is much thinner than the broader PBM internet narrative suggests.\n\n## What this page is trying to answer\n\nThis page asks a narrow question: if someone uses a **nonthermal whole-body red/NIR light-bed setup** in a consistent, explicitly logged way for four weeks, is there a detectable personal signal in sleep, next-day sleepiness, recovery, or resting heart rate?\n\n## Why this version is cautious\n\nThe direct literature is not strong enough to promise a result. The strongest general-wellness controlled record in the landing set is a **partial-body** daytime 850 nm trial with winter-only mood, drowsiness, inflammatory, and resting-heart-rate signals but **no significant sleep or circadian benefit**. The direct whole-body sleep records are mainly registries that help with cadence, endpoints, and exclusions rather than with efficacy. Acute direct whole-body evidence also exists in a narrow women-only metabolic study, but that is not a general sleep study.\n\n## Who should not use this as an ordinary self-experiment\n\nDo not use this ordinary wellness protocol without clinician guidance if you are pregnant or breastfeeding; are under 18; have seizure risk, photophobia, photosensitivity, eye disease, recent eye surgery, active or recent cancer treatment, skin-cancer history, suspicious or changing skin lesions, thyroid disease, an implanted medical device, unstable cardiovascular, metabolic, neurologic, pulmonary, or psychiatric disease, diabetes medication constraints, open wounds, active rash, sunburn, skin infection, herpes outbreak, or recent photodynamic therapy drug exposure. Also do not use this protocol if you cannot reliably detect or report heat, pain, skin symptoms, or visual symptoms. These boundaries come from safety reviews, medication guidance, and supervised or registered protocol exclusions rather than from proven risk rates.\n\n\n## What stays separate\n\nThis page is not the place to import efficacy claims from athlete recovery beds, fibromyalgia or chronic-pain PBM, cosmetic or photoaging beds, transcranial or intranasal PBM, red-light glasses, bright-light therapy, infrared sauna, or UV tanning. The athlete/recovery bucket is mixed and includes null performance and fatigue-biomarker evidence; fibromyalgia and cosmetic signals are condition- or endpoint-specific. Those literatures help define boundaries, not generic efficacy.\n\n## Stop rules\n\nStop the session immediately for eye pain, blurred vision, visual disturbance, unusual light sensitivity, new floaters, a persistent afterimage, accidental direct gaze followed by lingering symptoms, burning or hot skin, blistering, persistent redness, rash, swelling, wound or lesion irritation, severe headache, dizziness, nausea, confusion, fainting, seizure symptoms, chest symptoms, palpitations, wheezing, unusual shortness of breath, or marked mood or sleep worsening. Do not finish sessions just to hit an adherence target. Eye, skin, medication, and mood-related adverse-event signals are mostly adjacent rather than direct whole-body evidence, which is exactly why the stop rules should be stricter than the efficacy language.\n\n## How to read your result\n\nA positive result would mean your own baseline shifted in a repeatable direction while device, timing, coverage, and other confounders stayed fairly stable. A null or mixed result is still informative here, and worsening sleep duration or sleep-stage estimates should be treated as a real negative signal rather than ignored, because adjacent repeated-use wearable data include both lower sleeping heart rate and shorter sleep durations.",
+      "slug": "protocols/whole-body-photobiomodulation/whole-body-red-and-near-infrared-light-exposure",
+      "status": "field-testing",
+      "summary": "Whole-body red/NIR light-bed exposure, where light reaches cells, changes how mitochondria handle energy and stress signals, and can release nitric oxide that relaxes blood vessels.",
+      "title": "Whole-Body Red and Near-Infrared Light Exposure",
+      "traits": {
+        "cautionLevel": "high",
+        "externalProtocol": false,
+        "highCaution": true,
+        "murphCanonical": false,
+        "sourceAttributed": false
+      }
     }
   ],
   "schemaVersion": "murph.commons.protocol-index.v1"